Congressional Consensus on Compounding Reform Stuck in Neutral

After three hearings on the pressing issue, House lawmakers have not reached a consensus on how to reform federal oversight of compounding pharmacies, casting doubt on whether Congress will be able to pass legislation the FDA says it wants.
Drug Industry Daily